Plenary session

Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting

Retrieved on: 
Wednesday, January 17, 2024
Senior, North American Neuromodulation Society, HFX, Patient, Medicine, PST, NANS, Pain management, University, Nervous system, Spinal cord stimulator, SCS, Chronic pain, Caesars Palace, Annual general meeting, Research fellow, University of Arkansas, Plenary session, Hertz, Dentistry

REDWOOD CITY, Calif., Jan. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company's HFX™ 10 kHz Therapy for patients with chronic pain. Results will be presented at the 2024 North American Neuromodulation Society (NANS) Annual Meeting held from January 18-21, 2024 at Caesars Palace Las Vegas.

Key Points: 
  • Results will be presented at the 2024 North American Neuromodulation Society (NANS) Annual Meeting held from January 18-21, 2024 at Caesars Palace Las Vegas.
  • A total of 25 scientific abstracts reviewing clinical results for 10 kHz Therapy™, including four podium presentations and 21 posters, will be presented at the conference.
  • "The growing body of clinical evidence from our 25 scientific abstracts displays the substantial benefits of 10 kHz Therapy and we look forward to continuing to treat underserved patient populations suffering from debilitating chronic pain."
  • The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Associa

Retrieved on: 
Tuesday, November 28, 2023
Plenary session, NPC, Food, Survival, Risk, ASCO, CHRS, HKEX, FDA, PD-1, Progression-free survival, Incidence, Society, Cisplatin, Cancer, UPMC Hillman Cancer Center, Annual general meeting, American Medical Association, Death, UPMC, Nature Medicine, Sun, EBV, Patient, OS, PFS, Journal, Development, PD-L1, GP, Pharmaceutical industry

REDWOOD CITY, Calif. And SHANGHAI, China, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) and Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180) announced today the publication of the final overall survival (OS) results from the pivotal JUPITER-02 study (NCT03581786), a randomized, double-blind, placebo-controlled, international, multi-center Phase 3 clinical trial evaluating the immune checkpoint inhibitor LOQTORZI™ (toripalimab-tpzi), in combination with the chemotherapy agents gemcitabine and cisplatin, as a first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) in the Journal of the American Medical Association (JAMA). As previously reported at the 2023 American Society of Clinical Oncologists (ASCO) Annual Meeting, the final analysis revealed a 37% reduction in the risk of death in NPC patients treated with toripalimab plus chemotherapy versus chemotherapy alone.

Key Points: 
  • Coherus plans to launch LOQTORZI in the United States in January 2024.
  • “There are limited options for patients living with this aggressive head and neck cancer.
  • The median OS was not reached in the LOQTORZI arm and was 33.7 months in the placebo arm.
  • The safety profile was consistent with that previously reported in other toripalimab clinical trials and consistent with the PD-1 inhibitor class.

Beijing Review：Aiming High

Retrieved on: 
Monday, December 18, 2023
World Trade Organization, Life expectancy, Social change, CPC, GDP, Communist party, Orbit, Movement, Health, COVID-19, Chinese Communist Party, Plenary session, Central committee, Poverty, New Year's, Renewable energy, Tourism

For instance, rural reforms ended collective farming, allowing households to regain the responsibility for decisions about inputs and outputs.

Key Points: 
  • For instance, rural reforms ended collective farming, allowing households to regain the responsibility for decisions about inputs and outputs.
  • China continued to integrate itself into the global economy, leading to its accession to the World Trade Organization in 2001.
  • Going forward, China will continue to be guided by the old adage, "Charge at the toughest and aim at the farthest."
  • With this in mind, it will press ahead with reform, break new ground, remove barriers and unleash more potential for development.

Opening Ceremony and Plenary Session Held at 2023 World Internet Conference Wuzhen Summit

Retrieved on: 
Thursday, November 9, 2023
Online, Digital, CRI, Network Computing System, Chinese Academy of Engineering, South Korea, Lenovo, World Internet Conference, Emeritus, Plenary session, Conference, Alibaba Group, Internet, Multimedia, Republic, Artificial intelligence, Union, University of the Chinese Academy of Sciences, All, American Academy of Arts and Sciences, American Academy, Science, Resilience, Community, WIC, Korea, IBM, Video game, Engineering

WUZHEN, China, Nov. 9, 2023 /PRNewswire/ -- A news report from CRI Online: The 2023 World Internet Conference (WIC) Wuzhen Summit Opening Ceremony and Plenary Session took place on November 8 with World Internet Conference Secretary General Ren Xianliang presiding.

Key Points: 
  • WUZHEN, China, Nov. 9, 2023 /PRNewswire/ -- A news report from CRI Online: The 2023 World Internet Conference (WIC) Wuzhen Summit Opening Ceremony and Plenary Session took place on November 8 with World Internet Conference Secretary General Ren Xianliang presiding.
  • During the events, memorial cups were presented to the winners of the Wuzhen Summit 10-Year Commemorative Honour, and the first group of World Internet Conference Global Youth Leaders received certificates marking their selection.
  • The 2023 WIC Wuzhen Summit is dedicated to "Creating an Inclusive and Resilient Digital World Beneficial to All — Building a Community with a Shared Future in Cyberspace", with 20 sub-forums on topics ranging from digital cooperation within the Global Development Initiative and collaborative green transformation toward digital sustainability to artificial intelligence (AI).
  • More than 1,800 online and offline participants from over 120 countries and regions worldwide are expected to take part.

ISAP2023: The 15th International Forum for Sustainable Asia and the Pacific: “Accelerating Sustainability Transitions in Asia and the Pacific: The Transformative Potential of Integration, Inclusion and Localisation”

Retrieved on: 
Wednesday, October 4, 2023
Sustainability, Professional Services, Environmental, Social and Governance (ESG), Environment, International Forum on Energy Security for the Future, Integration, ISAP, Government, NGO, Biodiversity, Newsletter, Pacifico Yokohama, IGES, Plenary session, Climate, Agriculture, Creative industries

The Institute for Global Environmental Strategies (IGES) will host the 15th International Forum for Sustainable Asia and the Pacific (ISAP2023).

Key Points: 
  • The Institute for Global Environmental Strategies (IGES) will host the 15th International Forum for Sustainable Asia and the Pacific (ISAP2023).
  • This year, the Plenary Sessions will be held on Tuesday, 19 December 2023 at Pacifico Yokohama as a hybrid event, with participation in-person and online.
  • In addition, the Thematic Tracks will be held online from October 2023 to January 2024.
  • Integration: Maximising synergies and minimising trade-offs across climate, biodiversity and circular economy are essential to advancing the sustainability agenda.

Healthcare Week boon for medical industry

Retrieved on: 
Thursday, May 18, 2023
Well, HKCEC, HKUST, HKU, Eye, Robotics, Transport, Chair, Communications and Information Technology Commission (Saudi Arabia), Convention center, Ageing, Hope, Innovation, Technology and Industry Bureau, Research, Government, Computer, Limited, HKTDC, HKBU, Hong Kong Trade Development Council Trade Fairs, Drug discovery, GSK, Health, Hong Kong International Medical Devices and Supplies Fair, Health care, Medicine, Plenary session, History, Global Health, Drawing, Cyberport, MOU, CUHK, ITC, Workforce, Activity, University, HKSAR, Woman, COVID, Polytechnic, Guangdong–Hong Kong–Macao Greater Bay Area, CBE, Summit, HK, Tutoring, Management, Tourism, Pharmaceutical industry, Creative industries, Fair, D

Two flagship events attract global healthcare elites, affirming confidence for Hong Kong's stronger role in the medical and healthcare sector in the region

Key Points: 
  • Two flagship events attract global healthcare elites, affirming confidence for Hong Kong's stronger role in the medical and healthcare sector in the region
    HONG KONG, May 18, 2023 - (ACN Newswire) - Global healthcare sector leaders streamed into Hong Kong for the second International Healthcare Week, organised by the Hong Kong Trade Development Council (HKTDC).
  • "The strong support from the healthcare industry for the Healthcare Week is overwhelming.
  • It has created synergies for medical and healthcare industry professionals and unleashed Hong Kong's strengths in upstream and downstream healthcare industries, Hong Kong is ready to play a bigger role in the medical and healthcare fields in the region," Dr Lam added.
  • A number of content-rich events, including the highly anticipated HKMHDIA Medical Fair Forum, were held during the Medical Fair with keen participation from industry professionals.

Entrinsic Bioscience Shares Breakthrough in Rehydration Technology at Prestigious Plenary Session During Digestive Disease Week

Retrieved on: 
Monday, May 8, 2023
Electrolyte, IBS-D, University, MBBS, EBS, Cholera toxin, Dehydration, Glucose, University of Florida, Booth, Gastroenteritis, Research, Plenary session, Dicarboxylic acid, Doctor of Philosophy, Radiation therapy, Patient, Standard of care, ORS, Water, Disease, Oral rehydration therapy, Infant, Mortality, WHO, GI, Dietary supplement, Pharmaceutical industry

Dr. Vidyasagar is also a founder of Entrinsic Bioscience and chair of the Entrinsic Scientific Advisory Board.

Key Points: 
  • Dr. Vidyasagar is also a founder of Entrinsic Bioscience and chair of the Entrinsic Scientific Advisory Board.
  • The paper, titled "Select Amino Acids (AA-ORS) Improve Electrolyte and Fluid Absorption in a Rodent Diarrhea Model" was presented yesterday by Astrid Grosche, PhD, University of Florida, at a Plenary Session during Digestive Disease Week (May 6-9) in Chicago.
  • These findings are expected to have a significant impact on the field as they represent a breakthrough in rehydration technology.
  • They will also discuss the launch of Enterade® IBS-D , which utilizes an Entrinsic patented amino acid combination in its formula.

Mitsubishi Tanabe Pharma America to Present Latest Findings Across ALS and Parkinson's Disease at 2023 American Academy of Neurology Annual Meeting

Retrieved on: 
Thursday, April 20, 2023
Mitsubishi Tanabe Pharma, Medical Affairs Bureau, PD, Edaravone, IV, Disease, Phase II, AAN, Safety, Rush University Medical Center, Efficacy, ALS, American Academy, Research, Plenary session, EDT, Data mart, Beyond, DSM-IV codes, MTPA, Parkinson's disease, CDM, Randomness, Annual general meeting, Oral, L-DOPA, Carbidopa/levodopa, FAAN, American Academy of Neurology, Pharmaceutical industry, Medicinal plants, Communications satellite, Boundless, Optum, Patient

JERSEY CITY, N.J., April 20, 2023 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced six presentations in amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) will be shared as part of the 2023 American Academy of Neurology (AAN) Annual Meeting, being held virtually and in Boston, Mass., April 22-27.

Key Points: 
  • JERSEY CITY, N.J., April 20, 2023 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced six presentations in amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) will be shared as part of the 2023 American Academy of Neurology (AAN) Annual Meeting, being held virtually and in Boston, Mass., April 22-27.
  • The latter will be presented orally as part of a Scientific Platform Session at the meeting.
  • All three studies are being conducted by NeuroDerm Ltd., a wholly owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC), MTPA's parent company.
  • Efficacy and Safety of Continuous Subcutaneous ND0612 Infusion Compared with Oral Immediate-release Levodopa-Carbidopa in Patients with Parkinson's Disease and Motor Fluctuations.

Latest news - Next DLAT Meetings - Delegation to the Euro-Latin American Parliamentary Assembly

Retrieved on: 
Tuesday, April 18, 2023
EUROLAT, EU, Plenary session, Property management, Music

Next DLAT Meetings

Key Points: 
  • Next DLAT Meetings
    17-04-2023 - 16:31
    26 June DLAT (in preparation of 3 July Bureau meeting) (Brussels)
    3 July EUROLAT BUREAU (in preparation of the EU-CELAC Summit) (Hybrid format)
    24-27 July EUROLAT 15th Plenary Session (Madrid)
    26 June DLAT (in preparation of 3 July Bureau meeting) (Brussels)
    3 July EUROLAT BUREAU (in preparation of the EU-CELAC Summit) (Hybrid format)
    24-27 July EUROLAT 15th Plenary Session (Madrid)

American Society for Laser Medicine and Surgery Hosts its 42nd Annual Conference

Retrieved on: 
Tuesday, March 14, 2023
Astronomy, DRS, Plenary session, Science, University, Society, Health, Conference, Physician, Phoenix Convention Center, MD, Laser, Medical device

WAUSAU, Wis., March 14, 2023 /PRNewswire-PRWeb/ -- The Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) is regarded as the top international meeting for the exchange of information on medical laser and energy-based technologies. 2023 marks the 42nd year of the ASLMS Annual Conference.

Key Points: 
  • The Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) is regarded as the top international meeting for medical laser and energy-based technologies.
  • WAUSAU, Wis., March 14, 2023 /PRNewswire-PRWeb/ -- The Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) is regarded as the top international meeting for the exchange of information on medical laser and energy-based technologies.
  • 2023 marks the 42nd year of the ASLMS Annual Conference.
  • Andrea Alstad, American Society for Laser Medicine and Surgery, 7158459283, [email protected]